<html>
<head>PUBMED IDs for LGMD2B</head>
<body bgcolor='#C5F0F2'><h1>LGMD2B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7795603/'>Genetic heterogeneity of autosomal recessive limb-girdle muscular dystrophy in a genetic isolate (Amish) and evidence for a new locus.</a> March 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899051/'>Limb-girdle muscular dystrophy: a follow-up study of 79 patients.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899049/'>Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8899048/'>Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.</a> September 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9027860/'>The molecular biology of LGMD2B--towards the identification of the LGMD gene on chromosome 2p13.</a> December 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9009996/'>Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy.</a> December 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9073523/'>Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B.</a> March 15  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9244444/'>Integrated radiation hybrid map of human chromosome 2p13: possible involvement of dynactin in neuromuscular diseases.</a> July 15  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9436434/'>[Miyoshi distal muscular dystrophy].</a> January 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9480219/'>[Mapping of the gene for autosomal-recessive progressive muscular dystrophy in an isolate from a highland region of Dagestan to chromosome 2-13].</a> February 28  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9570945/'>Generation of a 3-Mb PAC contig spanning the Miyoshi myopathy/limb-girdle muscular dystrophy (MM/LGMD2B) locus on chromosome 2p13.</a> May 8  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9572710/'>Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.</a> May 8  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9731527/'>A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.</a> September 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9805007/'>The genomic structure of DCTN1, a candidate gene for limb-girdle muscular dystrophy (LGMD2B).</a> November 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10069710/'>Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G.</a> March 9  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10196377/'>Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).</a> April 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10196375/'>Dysferlin is a plasma membrane protein and is expressed early in human development.</a> April 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10619713/'>A diagnostic fluorescent marker kit for six limb girdle muscular dystrophies.</a> January 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10995573/'>The third human FER-1-like protein is highly similar to dysferlin.</a> September 21  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11117547/'>Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.</a> December 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11134403/'>Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.</a> January 3  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11166162/'>Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations.</a> February 13  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11532985/'>The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.</a> September 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11555998/'>[LGMD2B(dysferlin deficiency)].</a> September 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11665864/'>Dysferlin protein analysis in limb-girdle muscular dystrophies.</a> October 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11891182/'>Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.</a> March 14  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12379311/'>Telethonin protein expression in neuromuscular disorders.</a> October 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12767493/'>Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.</a> May 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14560310/'>Characterisation of the dysferlin skeletal muscle promoter.</a> October 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14673575/'>Variable reduction of caveolin-3 in patients with LGMD2B/MM.</a> December 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14959561/'>Molecular bases of autosomal recessive limb-girdle muscular dystrophies.</a> February 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15293763/'>[A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy].</a> August 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316618/'>[Limb girdle muscular dystrophies].</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15469449/'>Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.</a> October 8  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15651352/'>[Limb-girdle muscular dystrophy; update].</a> January 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15835269/'>Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.</a> April 20  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16010686/'>Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.</a> July 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16447768/'>[Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].</a> February 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16797397/'>Loss of podocyte dysferlin expression is associated with minimal change nephropathy.</a> June 27  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16797386/'>Obesity is associated with family history of ESRD in incident dialysis patients.</a> June 27  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16817213/'>A case of dysferlinopathy presenting choreic movements.</a> July 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16934466/'>Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E.</a> August 29  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17132147/'>Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.</a> November 30  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17129727/'>Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.</a> November 30  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17331981/'>Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).</a> March 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17828519/'>Dysfunction of dysferlin-deficient hearts.</a> September 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17825554/'>Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.</a> September 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17994539/'>Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients.</a> November 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18202836/'>Animal models for genetic neuromuscular diseases.</a> January 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18294055/'>Dysferlin homozygous mutation G1418D causes limb-girdle type 2B in a Mexican family.</a> February 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18396043/'>Late onset in dysferlinopathy widens the clinical spectrum.</a> April 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18392839/'>Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.</a> April 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18583542/'>SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18832576/'>Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.</a> October 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18853459/'>Analysis of the DYSF mutational spectrum in a large cohort of patients.</a> October 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19326120/'>[Amyloidosis in muscular dystrophy].</a> August 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19493611/'>Novel DYSF mutations in Thai patients with distal myopathy.</a> September 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19493606/'>The V109G polymorphism in the p27 gene is associated with endometriosis.</a> October 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19755517/'>C. elegans dysferlin homolog fer-1 is expressed in muscle, and fer-1 mutations initiate altered gene expression of muscle enriched genes.</a> June 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20096397/'>Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.</a> March 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20145676/'>Therapeutic exon skipping for dysferlinopathies?</a> November 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20535123/'>Private dysferlin exon skipping mutation (c.5492G&gt;A) with a founder effect reveals further alternative splicing involving exons 49-51.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21119217/'>Reverse engineering gene network identifies new dysferlin-interacting proteins.</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21301039/'>[Miyoshi distal muscular dystrophy (Miyoshi myopathy)].</a> May 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21484829/'>Progressive dysphagia in limb-girdle muscular dystrophy type 2B.</a> June 8  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21484825/'>Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity.</a> June 8  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21496627/'>Dysferlinopathies.</a> July 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21522182/'>Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.</a> January 4  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21556485/'>Translational research and therapeutic perspectives in dysferlinopathies.</a> March 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22367358/'>Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy.</a> March 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22367357/'>Effect of vertebral fractures on function, quality of life and hospitalisation the AGES-Reykjavik study.</a> August 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22468107/'>Heterogeneous characteristics of Korean patients with dysferlinopathy.</a> July 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23185377/'>Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.</a> May 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23619364/'>Assessment of disease activity in muscular dystrophies by noninvasive imaging.</a> July 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24843229/'>Genetic basis of limb-girdle muscular dystrophies: the 2014 update.</a> August 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25574751/'>Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.</a> December 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25904108/'>Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.</a> April 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26916285/'>Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy.</a> December 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27558075/'>MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B.</a> February 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27558057/'>Alfred G. Knudson (1922-2016).</a> September 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28403181/'>Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing.</a> April 26  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28487742/'>Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy.</a> May 11  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28502335/'>Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.</a> June 16  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28502327/'>Fanconi Anemia and Laron Syndrome.</a> June 16  2017<br></body></html>
